HYPERTENSIVE

Clinical trials for HYPERTENSIVE explained in plain language.

Never miss a new study

Get alerted when new HYPERTENSIVE trials appear

Sign up with your email to follow new studies for HYPERTENSIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New weekly shot aims to tackle high blood pressure and obesity together

Disease control Recruiting now

This Phase 3 trial tests a drug called IBI362 in people with mild to moderate high blood pressure who are also overweight or obese. Participants receive weekly injections of either the drug or a placebo for 48 weeks. The main goal is to see if IBI362 lowers blood pressure more th…

Matched conditions: HYPERTENSIVE

Phase: PHASE3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control

Last updated Jun 23, 2026 11:58 UTC

HYPERTENSIVE

Get alerted when new HYPERTENSIVE trials appear

New weekly shot aims to tackle high blood pressure and obesity together